Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113214205B details a high-yield copper-catalyzed route for chromone derivatives, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel asymmetric catalytic synthesis method for Finerenone intermediates offering high purity and scalable production capabilities for global pharmaceutical supply chains.
Patent CN101362710A details a clean catalytic hydrogenation route for aminobenzenesulfonic acid, offering superior purity and eliminating iron mud waste for dye intermediates.
Patent CN101684078A reveals a high-yield BTC route for levetiracetam intermediates, offering safer production and reduced waste for global supply chains.
Patent CN101691332B details a novel two-stage hydrogenation method for 4-ADPA, offering superior purity and catalyst recovery for reliable supply chains.
Patent CN101225063A details a novel alkaline hydrolysis route for Cysteamine Hydrochloride, offering higher yields, shorter cycles, and enhanced safety for API manufacturing.
Novel electrochemical route for chloroethyl sulfoxide eliminates metal catalysts, offering cost reduction and high purity for pharmaceutical manufacturing supply chains.
Patent CN107056849A details mild I2-Et3SiH catalysis for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain reliability.
Patent CN101429199B details a mild two-step racemization process for fluoroquinolone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN111116531A reveals a novel one-step hydrogenation method for Ramelteon intermediates, offering superior purity and safer processing for pharmaceutical manufacturing.
Patent CN112442474B reveals a robust Fusarium oxysporum lactamase for optically pure (-) gamma-lactam production, offering superior stability and cost-effective manufacturing solutions.
Novel 1-aza-5-germanocarbobicyclo[3.3.3]undecane synthesis via patent CN112194674B. Stable air-tolerant intermediates for advanced material manufacturing.
Advanced preparation of Maropitant intermediates via transition metal catalysis. High purity, >99% ee, and scalable routes for pharmaceutical manufacturing.
Patent CN101289441A details a cost-effective urea-based synthesis for Carisoprodol. This method offers significant supply chain advantages and reduced manufacturing costs for API producers.
Patent CN102391243A details a novel 7-step synthesis for Atorvastatin intermediates, eliminating expensive lithium reagents and improving supply chain reliability.
Patent CN114437089A reveals a safer, high-yield route for Nalfurafine intermediate NAHY-2 using formic acid transfer hydrogenation, offering significant cost and supply chain advantages.
Patent CN113354599A reveals a safer, high-yield route for Nintedanib key intermediates using hydrazine reduction, offering significant cost reduction in API manufacturing.
Novel metal-free pyrrole synthesis patent offers high yield and reduced contamination for reliable pharmaceutical intermediate supply chains.
Patent CN103588841A details a novel ketalization method for high-purity estriol refining, offering significant cost reduction and supply chain reliability for hormone manufacturing.
Novel synthesis route for avanafil intermediate ensures high purity and safety. Cost-effective production scale-up for pharmaceutical supply chains globally seeking reliable partners.